Predictions
Sutro Biopharma Inc
Start price
Target price
Perf. (%)
€4.78
03.04.24
03.04.24
€9.25
03.04.25
03.04.25
-13.39%
29.08.24
29.08.24
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€885.20
03.04.24
03.04.24
€1,049.8
03.04.25
03.04.25
21.10%
30.08.24
30.08.24
Sutro Biopharma Inc
Start price
Target price
Perf. (%)
€4.78
03.04.24
03.04.24
€16.65
03.04.25
03.04.25
-13.39%
29.08.24
29.08.24
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€62.50
03.04.24
03.04.24
€79.68
03.04.25
03.04.25
6.40%
30.08.24
30.08.24
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€709.60
02.04.24
02.04.24
€831.01
02.04.25
02.04.25
22.63%
30.08.24
30.08.24
Gritstone Oncology Inc
Start price
Target price
Perf. (%)
€1.11
02.04.24
02.04.24
-
02.04.25
02.04.25
-38.74%
16.04.24
16.04.24
Could be very worthwhile Investment >20% year
Accelerate Diagnostics Inc.
Start price
Target price
Perf. (%)
€0.87
02.04.24
02.04.24
-
02.04.25
02.04.25
90.75%
29.08.24
29.08.24
Kala Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€7.37
02.04.24
02.04.24
€19.50
02.04.25
02.04.25
-27.02%
29.08.24
29.08.24
Gritstone Oncology Inc
Start price
Target price
Perf. (%)
€1.14
02.04.24
02.04.24
-
02.04.25
02.04.25
-28.14%
13.04.24
13.04.24
Could be worthwhile Investment >10% per year
Atossa Genetics Inc
Start price
Target price
Perf. (%)
€1.85
02.04.24
02.04.24
€3.72
02.04.25
02.04.25
-32.83%
30.08.24
30.08.24
Emergent Biosolutions Inc.
Start price
Target price
Perf. (%)
€2.01
02.04.24
02.04.24
-
02.04.25
02.04.25
442.04%
17.08.24
17.08.24
Probably not worthwhile Investment
Higher risks for its business
Gritstone Oncology Inc
Start price
Target price
Perf. (%)
€1.28
02.04.24
02.04.24
-
02.04.25
02.04.25
-62.71%
17.08.24
17.08.24
Probably not worthwhile Investment
Below average Marketposition
Higher risks for its business
Gritstone Oncology Inc
Start price
Target price
Perf. (%)
€1.60
02.04.24
02.04.24
-
02.04.25
02.04.25
-48.88%
13.04.24
13.04.24
Probably not worthwhile Investment
Revenue decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
Corvus Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€1.67
01.04.24
01.04.24
-
01.04.25
01.04.25
141.64%
30.08.24
30.08.24